Krystal Biotech, Inc. (KRYS)
288.31
-0.68
(-0.24%)
USD |
NASDAQ |
May 07, 10:44
Krystal Biotech Cash from Investing (Quarterly) : -63.58M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Scholar Rock Holding Corp. | 38.97M |
| Stoke Therapeutics, Inc. | -61.06M |
| Moderna, Inc. | -76.00M |
| Alnylam Pharmaceuticals, Inc. | -25.54M |
| TG Therapeutics, Inc. | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 80.38M |
| Cash from Financing (Quarterly) | -10.46M |
| Free Cash Flow | 237.38M |
| Free Cash Flow Per Share (Quarterly) | 2.401 |
| Free Cash Flow to Equity (Quarterly) | 73.46M |
| Free Cash Flow to Firm (Quarterly) | 73.23M |
| Free Cash Flow Yield | 2.74% |